Hospitalizations for Respiratory Syncytial Virus and Vaccine-Preventable Infections in the First 2 Years After Pediatric Liver Transplant
- PMID: 28088400
- DOI: 10.1016/j.jpeds.2016.12.021
Hospitalizations for Respiratory Syncytial Virus and Vaccine-Preventable Infections in the First 2 Years After Pediatric Liver Transplant
Abstract
Objectives: To examine in liver transplant recipients at centers participating in the Pediatric Health Information System dataset the number of hospitalizations for respiratory syncytial virus (RSV) and vaccine-preventable infections (VPIs) in the first 2 years after transplantation, morbidity and mortality associated with these hospitalizations, and costs associated with these hospitalizations.
Study design: A retrospective cohort study of patients <18 years of age who underwent liver transplantation at a Pediatric Health Information System center between January 1, 2004, and December 31, 2012. Hospitalizations for RSV/VPIs during the first 2 years post-transplant were ascertained using International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes. Data were collected on clinical care, outcomes, and costs during these hospitalizations.
Results: There were 2554 liver transplant recipients identified; 415 patients (16.3%) had 544 cases of RSV/VPIs. RSV, rotavirus, and influenza were the most common infections resulting in hospitalization. Ninety-two patients (3.6%) had RSV/VPI during their transplant hospitalization. Transplant hospitalizations complicated by RSV/VPI were longer (44 days vs. 21 days; P < .001), had higher rejection rates (37% vs. 26%; P = .02), and were more expensive ($259 697 vs. $190 860; P < .001). Multivariate analyses identified age <2 years at transplant (P < .001) and multivisceral recipient (P = .04) as predictors of a hospitalization for RSV.
Conclusions: VPIs occurred in 1 of 6 liver transplant recipients in the first 2 years post-transplant, a significantly higher rate than in the general pediatric population. These hospitalizations had substantial morbidity, mortality, and costs, demonstrating the importance of vaccinating patients before transplantation.
Keywords: RSV; immunizations; influenza; vaccinations.
Copyright © 2016 Elsevier Inc. All rights reserved.
Comment in
-
Optimize vaccination of patients with liver transplant.J Pediatr. 2017 Mar;182:2. doi: 10.1016/j.jpeds.2017.01.005. J Pediatr. 2017. PMID: 28237445 No abstract available.
Similar articles
-
Hospitalizations for Respiratory Syncytial Virus and Vaccine Preventable Infections following Pediatric Heart Transplantation.J Pediatr. 2021 Sep;236:101-107.e3. doi: 10.1016/j.jpeds.2021.05.025. Epub 2021 May 14. J Pediatr. 2021. PMID: 34000283
-
Incidence of Hospitalization for Vaccine-Preventable Infections in Children Following Solid Organ Transplant and Associated Morbidity, Mortality, and Costs.JAMA Pediatr. 2019 Mar 1;173(3):260-268. doi: 10.1001/jamapediatrics.2018.4954. JAMA Pediatr. 2019. PMID: 30640369 Free PMC article.
-
Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006.Pediatr Infect Dis J. 2012 Jan;31(1):5-9. doi: 10.1097/INF.0b013e31822e68e6. Pediatr Infect Dis J. 2012. PMID: 21817948
-
What is the role of rapid molecular testing for seniors and other at-risk adults with respiratory syncytial virus infections?J Clin Virol. 2019 Aug;117:27-32. doi: 10.1016/j.jcv.2019.05.010. Epub 2019 May 25. J Clin Virol. 2019. PMID: 31158780 Review.
-
Under-immunization of pediatric transplant recipients: a call to action for the pediatric community.Pediatr Res. 2020 Jan;87(2):277-281. doi: 10.1038/s41390-019-0507-4. Epub 2019 Jul 22. Pediatr Res. 2020. PMID: 31330527 Free PMC article. Review.
Cited by
-
Immunization status and hospitalization for vaccine-preventable and non-vaccine-preventable infections in liver-transplanted children.World J Hepatol. 2021 Jan 27;13(1):120-131. doi: 10.4254/wjh.v13.i1.120. World J Hepatol. 2021. PMID: 33584991 Free PMC article.
-
Approach to vaccinating the pediatric solid organ transplant candidate and recipient.Front Pediatr. 2023 Nov 8;11:1271065. doi: 10.3389/fped.2023.1271065. eCollection 2023. Front Pediatr. 2023. PMID: 38027303 Free PMC article.
-
Feasibility, Acceptability, and Effectiveness of a Smartphone App to Increase Pretransplant Vaccine Rates: Usability Study.JMIR Form Res. 2025 Apr 15;9:e68855. doi: 10.2196/68855. JMIR Form Res. 2025. PMID: 40237553 Free PMC article.
-
The impact of COVID-19 on the pediatric solid organ transplant population.Semin Pediatr Surg. 2022 Jun;31(3):151178. doi: 10.1016/j.sempedsurg.2022.151178. Epub 2022 May 14. Semin Pediatr Surg. 2022. PMID: 35725046 Free PMC article. Review.
-
The limits of refusal: An ethical review of solid organ transplantation and vaccine hesitancy.Am J Transplant. 2021 Aug;21(8):2637-2645. doi: 10.1111/ajt.16472. Epub 2021 Jan 23. Am J Transplant. 2021. PMID: 33370501 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical